Gabor Varadi is an Oncology physician affiliated with Sidney Kimmel Cancer Center. OpenAlex indexes 94 publications with 4,594 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5501 Old York Rd
Philadelphia, PA 191413018
Telephone
215-456-7000Registry record last updated 6 Mar 2012.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Agios Pharmaceuticals, Inc.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- GlaxoSmithKline, LLC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
44.3%Kinase inhibitor15.6%Brukinsa30%Jakafi23%Imbruvica17%Ibrance16%Imatinib Mesylate14%Part D<11 patientsThalidomide Analog15.4%Lenalidomide37%Revlimid37%Pomalyst26%Part D<11 patients+ 3 more classes in this area
Blood & clotting
17.6%Factor Xa inhibitor13.6%Eliquis73%Xarelto27%Part D<11 patientsLow Molecular Weight Heparin4%Enoxaparin Sodium100%Part D<11 patientsMetabolism & gastrointestinal
12.6%Serotonin-3 Receptor Antagonist4%Ondansetron Odt100%Part D<11 patientsCorticosteroid3%Prednisone100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Obesity on Cancer-Specific Survival and Overall Survival in Colorectal Cancer
Nutrition and Cancer
2025 - An 80-Year-Old Man with Ischemic Heart Disease Who Developed Thrombotic Thrombocytopenic Purpura Following Treatment with Ticagrelor
American Journal of Case Reports
2022 - S2780 Nivolumab as a Bridge to Liver Transplantation in Advanced Hepatocellular Carcinoma
The American Journal of Gastroenterology
2021 - Falsely positive heparin‐induced thrombocytopenia antibody testing in severe hyperbilirubinemia
Research and Practice in Thrombosis and Haemostasis
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Marcia Brose, MD
Sidney Kimmel Cancer Center
Michael Millenson, MD
Sidney Kimmel Cancer Center
John Lauriello, MD
Sidney Kimmel Cancer Center
Thomas Guzzo, MD
Sidney Kimmel Cancer Center
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”